Expansion through acquisition HRS recently acquired Rimidi, signaling a strategic push into chronic disease management and broader cardiometabolic care. This creates upsell and cross-sell opportunities with Rimidi’s existing clients and expands HRS’s addressable market in longitudinal care.

Comprehensive longitudinal care With PatientFirst Pathways launched to enable connected, continuous care at home across the full patient journey, there is a sales lever to position HRS as the end-to-end platform for health systems seeking sustained remote care capabilities, potentially reducing home care fragmentation.

Enterprise integration strength Out-of-the-box HL7 integration with major EHR brands and strong partnerships suggest a low-friction deployment value proposition for health systems and IDNs seeking scalable RPM and CCM solutions, opening doors with CIOs and IT leaders.

Industry recognition Consistent awards and accolades from KLAS, Frost & Sullivan, US News, and Avia enhance credibility for sales conversations, particularly when engaging risk-averse customers prioritizing proven outcomes, value leadership, and partner ecosystems.

Financial and scale signals Revenue in the tens of millions and substantial funding indicate growth trajectory and operational maturity, making HRS a compelling partner for expansion deals, channel collaborations, and enterprise-level contracts with larger health networks.